![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/hepagene-therapeutics-announces-fda-clearance-of-investigational-new-drug-application-ind-for-hpg7233-thr-beta-agonist-301933223.html
https://www.prnewswire.com/news-releases/hepagene-therapeutics-to-present-at-the-european-association-for-the-study-of-the-liver-easl-congress-2023-301834650.html
https://www.pharmacompass.com/pdf/news/hepagene-therapeutics-initiates-the-rise-study-a-phase-iia-clinical-trial-of-hpg1860-in-patients-with-nash-1641805439.pdf
https://www.prnewswire.com/news-releases/hepagene-therapeutics-initiates-the-rise-study-a-phase-iia-clinical-trial-of-hpg1860-in-patients-with-nash-301434639.html
https://www.prnewswire.com/news-releases/hepagene-therapeutics-inc-announces-positive-results-from-phase-i-trial-of-hpg1860-301359762.html